Privitera, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 160
EU - Europa 113
AS - Asia 8
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 284
Nazione #
US - Stati Uniti d'America 160
SE - Svezia 45
IT - Italia 22
IE - Irlanda 16
DE - Germania 10
FR - Francia 8
IR - Iran 4
BE - Belgio 3
CZ - Repubblica Ceca 3
CI - Costa d'Avorio 2
IN - India 2
UA - Ucraina 2
AZ - Azerbaigian 1
CH - Svizzera 1
CN - Cina 1
EU - Europa 1
FI - Finlandia 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 284
Città #
Chandler 55
Ashburn 23
Dublin 16
New York 14
Marseille 7
Bremen 6
Princeton 6
Cagliari 5
Boston 4
Milan 4
Brussels 3
San Mateo 3
Abidjan 2
Brdo 2
Fairfield 2
Kish 2
Los Angeles 2
Pavia 2
Pune 2
Rome 2
San Diego 2
Washington 2
Ann Arbor 1
Atlanta 1
Baku 1
Beijing 1
Bellano 1
Boydton 1
Brno 1
Chicago 1
Corigliano d'Otranto 1
Kashan 1
Lappeenranta 1
Rotterdam 1
Sacramento 1
Seattle 1
Taranto 1
Wilmington 1
Zurich 1
Totale 183
Nome #
Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence 56
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. 49
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 42
Novel Insights Into the Interactions Between the Gut Microbiome, Inflammasomes, and Gasdermins During Colorectal Cancer 36
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 36
Predictors and early markers of response to biological therapies in inflammatory bowel diseases 33
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 26
The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19 14
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study 4
Totale 296
Categoria #
all - tutte 1.679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.679


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 1 0 0 1 5 0
2021/202252 1 0 1 4 0 3 0 5 0 10 13 15
2022/2023152 22 21 14 25 10 11 10 9 27 2 1 0
2023/202485 4 21 6 9 5 23 7 1 5 4 0 0
Totale 296